Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Clinical trial NCT02968368 · COMPLETED
Trial details
- NCT number
- NCT02968368
- Sponsor
- Shield Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2018-01-18
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.